Statistics in Medicine

Papers
(The H4-Index of Statistics in Medicine is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Testing and correcting for weak and pleiotropic instruments in two‐sample multivariable Mendelian randomization273
Minimum sample size for external validation of a clinical prediction model with a binary outcome150
Evaluation of various estimators for standardized mean difference in meta‐analysis103
Pleiotropy robust methods for multivariable Mendelian randomization97
Minimum sample size for external validation of a clinical prediction model with a continuous outcome61
Using propensity scores to estimate effects of treatment initiation decisions: State of the science60
Win odds: An adaptation of the win ratio to include ties42
A modified self‐controlled case series method for event‐dependent exposures and high event‐related mortality, with application to COVID‐19 vaccine safety41
Fine‐Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 141
Minimum sample size calculations for external validation of a clinical prediction model with a time‐to‐event outcome41
A comparison of different methods to adjust survival curves for confounders39
Bayesian workflow for disease transmission modeling in Stan36
Estimating heterogeneous survival treatment effect in observational data using machine learning35
Extending the Mann‐Whitney‐Wilcoxon rank sum test to survey data for comparing mean ranks34
Introduction to computational causal inference using reproducible Stata, R, and Python code: A tutorial33
Twenty years since Joinpoint 1.0: Two major enhancements, their justification, and impact33
An overview and critique of the use of cumulative sum methods with surgical learning curve data31
A tutorial on individualized treatment effect prediction from randomized trials with a binary endpoint31
Monitoring COVID‐19 contagion growth30
Propensity score weighting for covariate adjustment in randomized clinical trials28
Penalized regression for left‐truncated and right‐censored survival data26
TITE‐BOIN12: A Bayesian phase I/II trial design to find the optimal biological dose with late‐onset toxicity and efficacy26
Propensity‐score‐based meta‐analytic predictive prior for incorporating real‐world and historical data26
A note on estimating the Cox‐Snell R2 from a reported C statistic (AUROC) to inform sample size calculations for developing a prediction model with a bin26
Nowcasting COVID‐19 incidence indicators during the Italian first outbreak24
0.056649923324585